Methods Of Use For Il-22 In The Treatment Of Gastrointestinal Graft Vs. Host Disease

Patent No. EP3065777 (titled "Methods Of Use For Il-22 In The Treatment Of Gastrointestinal Graft Vs. Host Disease") was filed by Evive Biotechnology Shanghai on Nov 7, 2014. The application was issued on Jul 12, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANFeb 14, 2020MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3065777

EVIVE BIOTECHNOLOGY SHANGHAI
Application Number
EP14860998A
Filing Date
Nov 7, 2014
Status
Patent Maintained As Amended
Jun 9, 2023
Publication Date
Jul 12, 2023